---
figid: PMC10308629__10020_2023_687_Fig11_HTML
pmcid: PMC10308629
image_filename: 10020_2023_687_Fig11_HTML.jpg
figure_link: /pmc/articles/PMC10308629/figure/Fig11/
number: Fig. 11
figure_title: ''
caption: Tanshinone IIA reduced AQP1 and AQP3 expressions in normal hAECs via GSK-3β
  signaling pathway. A Western blotting of GSK-3β, p-GSK-3β, AQP1 and AQP3 proteins
  expression in hAECs with normal AFV. B–E Quantification of the expressions of GSK-3β,
  p-GSK-3β, AQP1, AQP3 relative to Tubulin. * and △ represent significant difference
  compared with control group and Tanshinone IIA group, respectively, P < 0.05. hAECs
  human amniotic epithelial cells, AFV amniotic fluid volume
article_title: 'Tanshinone IIA changed the amniotic fluid volume and regulated expression
  of AQP1 and AQP3 in amniotic epithelium cells: a promising drug treating abnormal
  amniotic fluid volume.'
citation: Shuangjia Pan, et al. Mol Med. 2023;29:83.
year: '2023'

doi: 10.1186/s10020-023-00687-6
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: BioMed Central

keywords:
- Tanshinone IIA
- Abnormal amniotic fluid volume
- Aquaporins
- Fetal membranes
- Glycogen synthetic kinase 3β
- AQP1 knockout

---
